跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUPREMINE ER phentermine (as hydrochloride) 30 mg extended release tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
SUPREMINE ER phentermine (as hydrochloride) 30 mg extended release tablet blister pack
Approved
STANDARD
SUPREMINE ER phentermine (as hydrochloride) 30 mg extended release tablet blister pack
Juno PC Holdings Pty Limited
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
66c4fb71faa3094c
Company
Juno PC Holdings Pty Limited
Type
Standard
Approval Details
Approval Id
66c4fb71faa3094c
Product Name
SUPREMINE ER phentermine (as hydrochloride) 30 mg extended release tablet blister pack
Artg Id
344057
Artg Name
SUPREMINE ER phentermine (as hydrochloride) 30 mg extended release tablet blister pack
Sponsor
Juno PC Holdings Pty Limited
Artg Date
2021-10-20
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/3e353e44766ab2646449b55f0e74fa00.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/bdfe3a1a268c2f5ac48c27e0859805ea.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
66c4fb71faa3094c
Type
Standard
Back to TGA Approvals